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Abstract The aim of the study was to evaluate zinc levels in three biological compartments
(serum, erythrocytes and hair) in patients with rheumatoid arthritis (RA) as compared to
healthy individuals. Zinc levels in serum, erythrocytes and hair (in 74 patients with RA and
30 healthy individuals) were assessed by atomic absorption spectroscopy. The mean hair
zinc content was significantly lower in RA patients as compared to healthy individuals (p<
0.001). Moreover, a positive correlation was observed in the RA patient group between the
erythrocyte zinc levels and the prednisone dose (rs=0.48, p<0.05), and a negative
correlation was found in this population between the serum zinc levels and disease duration
(rs=−0.42, p<0.0006). In conclusion, it seems that hair may be a useful complementary
study material for evaluating “zinc status” in rheumatoid arthritis patients.
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Rheumatoid arthritis (RA) is a well-studied progressive autoimmune disease. However, no
factor responsible for the immune system activation in the course of the disease has been
identified to date [1]. Among the many contributing agents that have been proposed to take
part in the pathogenesis of this condition, trace elements, including zinc, have also been
investigated [2–5]. The evidence for their involvement stems from the observation that
postmenopausal women consuming higher amounts of zinc are at a lower risk of RA (RR=
0.39, 95% CI=0.17–0.88, p<0.03) [6].
It has been shown that reactive oxygen species play a role in the aetiology of RA [1, 6–
10] and that one of them is the superoxide radical, which is eliminated by superoxide
dismutase—an enzyme containing zinc in its molecule [3, 5, 11]. It has also been found that
over 90% of this trace element present in erythrocytes is bound with carbonic anhydrase
and superoxide dismutase [12]. Furthermore, zinc mobilises vitamin A, a potent
antioxidant, from the liver, thus maintaining its proper levels in the blood [11].
Zinc is crucial for the proper functioning of approximately 300 hormones and enzymes in
the human body[11, 12], the latter representing all the classes taking part in the synthesis and
degradation of proteins, carbohydrates, fats and nucleic acids. Zinc constitutes a structural
element of alkaline phosphatase (ALP), with four of its atoms being present in the enzyme.
Zinc also stimulates ALP synthesis in osteoblasts and plays an important role in bone
mineralisation [13]. In addition, zinc is responsible for the latency of metalloproteinases (such
as collagenases, gelatinases, stromelysins, matrilysin, metalloelastases and membrane
metalloproteinases) by means of a coordination bond between a zinc atom in the centre of
the enzyme and a free cysteine–SH group present in the pro-peptide. Notably, the breaking of
this bond and the release of the pro-peptide result in the activation of metalloproteinases
responsible for articular cartilage destruction observed in RA [11, 12, 14].
Zinc deficiency has been previously studied in an experimental human model involving
males on a low-zinc diet (mild zinc deficiency) [15]. The reported effects included lowered
plasma testosterone levels, oligozoospermia, decreased natural killer cell function, reduced
interleukin 2 production, low thymulin levels, hyperammonaemia, diminished sensitivity to
different tastes, impaired adaptation to the dark and decreased lean body mass.
The investigators’opinionsonthezincstatusinthehuman bodyvary,particularlyinrespect
to this element’s serum, plasma and erythrocyte levels. Relatively few publications addressing
the zinc content in hair are available [16–19], and there seems to be no reports on its
assessment in RA patients. Thus, the authors of the present study undertook the task of
evaluating the content of this bioelement in serum, erythrocytes as well as hair of patients
with rheumatoid arthritis.
The aim of this work was to examine the differences between the levels of zinc present
in three fundamental biological compartments in patients with RA and in healthy
individuals, with a particular focus on hair.
Material and Methods
Study Population
Seventy-four patients treated for RA were evaluated in two specialist Rheumatology
Outpatient Clinics in Szczecin, Poland. The studied group comprised 20 men and 54
women aged 29–50 (mean age, 39.8±6.1 years). The diagnosis of RA was based on
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[20].
RA patients were divided into four subgroups (listed below) depending on the received
pharmacological treatment during the previous 6 months prior to the study:
& MTX=patients treated with methotrexate (MTX) at a weekly dose range from 7.5 to
12.5 mg/week and non-steroidal anti-inflammatory drugs (NSAIDs);
& MTX+GC=patients treated as above but also receiving glucocorticoids (GC),
prednisone, at a dose of 5.0–12.5 mg daily;
& MTX+GC+Ca+D3=patients treated as above but also receiving calcium and vitamin
D3 (as means of preventing osteoporosis); and
& SAS=patients receiving sulphasalazine (SAS) at a dose of 1,500–2,000 mg/daily and
NSAIDs only.
The control group consisted of 30 healthy individuals reporting successively to the clinic
of two general practitioners in Szczecin for reasons unrelated to RA. This group comprised
8 men and 22 women aged 27–50 (mean age, 38.2±8.3 years).
The inclusion criteria applied to both groups were as follows:
1. No diuretics, hypotensive agents, anticonvulsants, antibiotics, vitamin supplements
containing studied elements or oral contraceptives (females) taken for at least 6 months
prior to the study;
2. Nutrition—following a normal diet;
3. No evident gastrointestinal or urinary disturbances or endocrine conditions;
4. Age below 50 and regular menstruation (females); and
5. Informed consent to take part in the study.
Study Design
All study participants had their medical history taken and underwent a physical examination
and had their zinc levels measured: in the extracellular fluid (serum) and in the intracellular
compartment (erythrocytes and hair).
The study has been accepted by the Bioethical Commission (Ethics Board) of the
Pomeranian Medical University in Szczecin for studies in human subjects.
Writteninformedconsentwasobtainedfromallpatientsfrombothstudyandcontrolgroups.
Biochemical Analysis
Serum and Erythrocyte Zinc Levels
Zinc levels in serum and in erythrocytes were measured by atomic absorption spectroscopy
(AAS) using either an acetylene–air or acetylene–nitrous oxide flame. The serum and erythrocyte
samples were prepared by mineralisation in a 5:2 mixture of ultrapure nitric acid and perchloric
acid until achieving completedestruction of the organic matrix. Next, the solution was transferred
quantitatively into a volumetric flask and filled up to the final volume with deionised water.
Hair Zinc Content
Hair sections of 3–4 cm in length, measured from the skin, were collected from six to eight
scalp regions with stainless steel scissors to avoid contamination with other heavy metals.
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treatment was applied that might potentially alter the biological hair content of the studied
bioelements (the hair was not dyed, permanent waved, conditioned, etc.). The hair samples
were washed with a water solution of non-metal detergent, rinsed with deionised water and
dried at 60°C. Next, they were rewashed with a mixture of anhydrous alcohol and acetone
for 25 min, dried at 60°C and placed in a desiccator for 24 h. Subsequently, the hair
samples were weighed using analytical scales and subjected to mineralisation with a
mixture of ultrapure concentrated nitric acid and perchloric acid at a ratio of 5:2 (v/v). The
mineralisation process was conducted at the boiling point of the acid mixture, with water
and excess acids being distilled off to approximately one third of the original sample
volume. The remaining solution was transferred quantitatively to 25-cm
3 glass flasks and
filled to volume with water distilled three times with a quartz distillation apparatus [23].
The zinc content was assessed by AAS using either an acetylene–air or acetylene–nitrous
oxide flame. The measurements were conducted with a Pay-Unicam SP-9 spectrophotometer
interfaced with a computer.
The levels of zinc in serum, erythrocytes and hair were analysed at the Institute of
Quantum Electronics, Military Technical Academy, Warsaw, Poland.
Statistical Analysis
Statistical analysis was performed using the StatSoft Polska v. 9.0 package (StatSoft Inc.,
Tulsa, Oklahoma, USA).
The distribution type of the studied parameters within the analysed groups was
determined based on the Shapiro–Wilk test for normality (N), sample size (n), range of
values (range), median (Me), mean x ðÞand standard deviation (SD). The results from two
independent groups were compared using the Student’s t test (when the distribution of a
given parameter was not significantly different statistically from the normal distribution in
any of the comparison groups) or the Mann–Whitney U test (when the distribution of a
given parameter was significantly different statistically from the normal distribution in at
least one of the groups being compared).
In order to determine a statistical relationship between two variables, either the Pearson’s
(linear) correlation coefficient (when both variables had normal distribution) or Spearman’s
rank correlation coefficient (with at least one variable not having the normal distribution)
were used.
In all comparisons, the adopted significance threshold was p value ≤0.05.
Results
Table 1 shows the distribution patterns of the quantitative parameters in RA patients: mean
disease duration, RA clinical activity such as the Ritchie articular index for joint tenderness
[21] as well as the subjective joint pain score based on the visual analogue scale (VAS), and
haematology test results for erythrocyte sedimentation rate (ESR) and haemoglobin (Hb)
level. Additionally, the disease activity of RA was determined with the disease activity
score including 28 joints using ESR (DAS28-ESR) [22].
Table 2 presents the comparison of zinc levels in serum, erythrocytes and hair from
patients with RA and from healthy individuals. Statistically significant lower zinc
levels were found in RA patients versus control group, but only for the hair
compartment (p<0.001).
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zinc levels between the treatment subgroups irrespective of the evaluated biological
compartment (Table 3).
Table 4 presents the values of Spearman’s rank correlation coefficients (rs) for statistical
dependence between the zinc levels in studied biological compartments and the doses of
administered MTX and prednisone (GC). A positive correlation was observed between the
erythrocyte zinc levels and the glucocorticoid dose (rs=0.48, p<0.05).
Table 5 presents the relationship between the evaluated parameters and the levels of zinc in
each of the biological compartments. The only statistically significant correlation (a negative
one) was observed between the serum zinc levels and the disease duration (rs=−0.42, p<
0.0006). No correlation was established between the zinc levels in the analysed biological
compartments and disease activity determined by DAS28.
Discussion
Our evaluation of the zinc content in the hair of patients with RA is a pioneering study on
“zinc status” in RA patients. The available literature offers reports focussing solely on the
examination of zinc levels in plasma/serum, urine and, rarely, in erythrocytes of patients
with RA [2, 24–29]. The hair is a practical material for conducting bioelement analysis
since, similar to skin, myocardium and skeletal muscles, it constitutes a more stable depot
of elements than blood serum or erythrocytes [11, 16, 17, 19, 23]. Growing at a rate of 1.0–
2.0 cm per month, hair along its entire length constitutes a specific reflection of all the
biochemical events occurring in the body [17, 18]. Unlike tissues, hair is the end metabolic
product, with various elements incorporated into its composition as it grows. Upon reaching
the skin surface, the hair hardens and keratinises, and the elements accumulated during its
formation become embedded in its protein structure [17]. The present study demonstrates
Table 1 Study group characteristics (patients with RA, n=74)
Parameter Normality of distribution Range Median Mean ± SD
Mean disease duration (years) − 1.0–28.0 7.7 8.5±6.7
Ritchie articular index (points) − 2.0–19.0 8.1 8.2±3.4
VAS (cm) − 2.0–8.5 5.2 5.1±1.7
ESR (mm/h) − 2.0–93.0 31.2 37.2±25.1
Hb (g/dL) + 10.5–15.1 12.7 12.8±0.9
DAS28 − 2.6–6.5 5.1 4.9±0.9
Table 2 Comparison of mean zinc levels in serum, erythrocytes and hair of patients with RA versus the
control group
Type of sample in which mean zinc
levels/content were assessed
RA patients (n=74) Control group (n=30) p value
Serum (μg/dL) 80.1±12.5 72.0±8.0 NS
Erythrocytes (μg/dL) 968.2±113.9 1008.9±46.9 NS
Hair (μg/g d.h.m.) 160.9±27.4 190.8±29.9 <0.001
d.h.m. dry hair mass
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individuals and is not dependent on the applied treatment regimen. It therefore seems that
the evaluation of the zinc content in hair could be a useful complementary diagnostic
method to determine “zinc status” in rheumatoid arthritis patients. Moreover, the fact that
this particular evaluation method is completely noninvasive is of significance.
The serum zinc level was also examined in the present study, following on from the fact
that it is the standard test for assessing the status of this element in the body. It was
demonstrated here, as by other authors previously [28, 29], that RA patients’ zinc levels in
this particular biological compartment are higher, albeit not statistically significantly, than
those in healthy individuals. This is surprising as the levels of this element in rheumatoid
arthritis should presumably be decreased, considering the fact that the pro-inflammatory
cytokines (IL-1 and TNF-α)[ 28] involved in the pathogenesis of this condition inhibit the
synthesis of albumins in the liver and decrease their zinc-binding capacity, which in turn
should lead to lower levels of plasma zinc [11]. Zoli et al. [5] have demonstrated this in
their studies, showing a negative correlation between the levels of IL-1β and TNF-α and
zinc levels. The authors have argued that the observed association results from the
accumulation of zinc in the liver and inflamed joints caused by elevated IL-1β. It seems
plausible that the lack of consistency in the available reported data may be due to the
rapidly changing plasma zinc levels influenced by such factors as diet, disease activity,
pharmacological therapy (e.g. the use of antibiotics, laxatives, diuretics, sedatives,
hypnotics and anticonvulsants) [24, 30]. Notably, oral contraceptives may also cause a
decrease in plasma zinc levels [12]. However, the present study did not show any
association between the level of zinc in patient’s serum and the type of applied
pharmacological treatment, although a negative, highly statistically significant correlation
Table 3 Comparison of mean zinc levels in patients with RA depending on the pharmacological treatment
used
Type of sample in which mean
zinc levels/content were assessed
Treatment regimen p value
MTX
(n=19)
MTX+GC
(n=17)
MTX+GC+Ca+D3
(n=20)
SAS
(n=18)
Serum (μg/dL) 84.1±18.2 80.7±11.9 78.8±8.2 76.9±11.5 NS
Erythrocytes (μg/dL) 976.3±131.4 953.2±101.9 965.4±122.6 977.1±99.8 NS
Hair (μg/g d.h.m.) 146.9±40.9 153.4±13.1 163.7±25.8 179.7±29.7 NS
MTX methotrexate, GC prednisone, Ca calcium, D3 vitamin D3, SAS sulphasalazine, d.h.m. dry hair mass
Table 4 Correlation between the levels of zinc in serum, erythrocytes and hair and the doses of MTX or
prednisone (GC)
Type of sample in which mean zinc levels/content were assessed Spearman’s rank correlation coefficient
MTX (n=56) GC (n=37)
Serum (μg/dL) 0.14 0.04
Erythrocytes (μg/dL) 0.33 0.48*
Hair (μg/g d.h.m.) 0.40 −0.27
d.h.m. dry hair mass
*p<0.05
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consistent with findings reported by Çaglayan and Sükrü Aydog [25], suggesting that such
an effect may be partly due to secondary eating disorders often observed in chronic
inflammatory conditions.
Thereisaconsiderableamountofdatademonstratingthatplasmazincconstitutes<1%ofits
total content in the body, with approximately 99% of this bioelement being located
intracellularly[12]. Taking this into consideration, the assessment of zinc level in erythrocytes
was also performed since these cells represent a more stable pool than serum and plasma [3,
26, 27]. Therefore, the examination of zinc levels in this biological compartment was
performed in the present study as well. The obtained results indicated that the erythrocyte
zinc levels might be lower in RA patients as compared to healthy individuals, but this
difference was not statistically significant. The small number of publications on zinc
concentrations in erythrocytes of RA patients provide inconsistent data, showing either higher
[3, 26] or lower levels [27] in comparison to control groups. Over 90% of zinc contained in
red blood cells is bound with superoxide dismutase and carbonic anhydrase [12]. Tuncer et al.
[3] have reported an increased activity of superoxide dismutase in the erythrocytes of RA
patients. The results obtained in the present study may reflect intensified utilisation of zinc by
red blood cells. On the other hand, animal studies have demonstrated an increased fragility of
erythrocytes due to low zinc content in their cell membranes [12]. This might lead to a
leakage of the intra-erythrocyte zinc pool into the extracellular space—an effect that could be
the underlying cause of the results obtained in the present study.
The positive correlation found in the present study between the dose of glucocorticoid
and erythrocyte zinc level may result from glucocorticoid action, the reduction and
consequent inactivation of active oxygen forms. Free oxygen radicals are known as lipid
peroxidation inductors, and the peroxidation of the lipids changes the structure and function
of cell membranes and inactivates cell membrane enzymes [1, 7].
Conclusion
It seems that the evaluation of zinc content in hair could be a useful complementary
diagnostic method to determine “zinc status” in rheumatoid arthritis patients. Still, our
Table 5 Values of Spearman’s rank correlation coefficients (rs) or Pearson’s (linear) correlation coefficients
(r) and levels of significance (p values) for the studied parameters in the group of patients with RA
Correlated parameters Type of sample in which mean zinc levels were assessed
Serum (μg/dL) Erythrocytes (μg/dL) Hair (μg/g d.h.m.)
Subject age (years) rs=−0.23 rs=−0.02 rs=−0.03
Mean disease duration (years) rs=−0.42* rs=0.09 rs=−0.01
Ritchie articular coefficient (score) rs= −0.11 rs=0.20 rs=−0.26
VAS (cm) rs=0.12 rs=0.07 rs=−0.26
ESR (mm/h) rs=0.03 rs=0.24 rs=0.08
Hb (g/dL) r=−0.17 r=0.03 r=−0.21
DAS28 rs=0.02 rs=0.33 rs=−0.08
d.h.m. dry hair mass
*p<0.0006
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Acknowledgements The study was conducted under the KBN [Polish Scientific Research Committee] grant
no. 6 P05B 126 20.
Open Access This article is distributed under the terms of the Creative Commons Attribution
Noncommercial License which permits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B (2007) Oxidative status in
rheumatoid arthritis. Clin Rheumatol 26:64–68
2. Naveh Y, Schapira D, Ravel Y, Geller E, Scharf Y (1997) Zinc metabolism in rheumatoid arthritis:
plasma and urinary zinc and relationship to disease activity. J Rheumatol 24:643–646
3. Tuncer S, Kamanli A, Akçil E, Kavas GO, Seckin B, Atay MB (1999) Trace element and magnesium
levels and superoxide dismutase activity in rheumatoid arthritis. Biol Trace Elem Res 68:137–142
4. Zimmermann-Górska I (1999) A modern therapeutic approach to rheumatoid arthritis [Współczesne
podejście do reumatoidalnego zapalenia stawów]. Alerg Asthma Immunol 4:83–90
5. Zoli A, Altomonte L, Caricchio R et al (1998) Serum zinc and copper in active rheumatoid arthritis:
correlation with interleukin 1β and tumour necrosis factor α. Clin Rheumatol 17:378–382
6. Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA (2003) Antioxidant micronutrients and risk
of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157:345–354
7. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation,
and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin
Biochem 38:981–986
8. Fautrel B, Bourgeois P (2000) Affections rheumatismales: généralités. Drugs 59(Spec. issue 1):1–9
9. Piotrowska-Jastrzębska J, Mikołuć B, Motkowski R (2002) Nutritional antioxidants in health and disease
[Rola antyoksydantów żywieniowych w stanie zdrowia i choroby]. Terapia 10:43–49
10. Sarban S, Isikan UE, Kocabey Y, Kocyigit A (2007) Relationship between synovial fluid and plasma
manganese, arginase, and nitric oxide in patients with rheumatoid arthritis. Biol Trace Elem Res 115:97–106
11. Tapiero H, Tew KD (2003) Trace elements in human physiology and pathology: zinc and metal-
lothioneins. Biomed Pharmacother 57:399–411
12. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79–118
13. Heath DA, Shaw NJ (2001) Calcium and bone metabolism. In: Brook C, Hindmarsh P (eds) Clinical
pediatric endocrinology, 4th edn. Blackwell Science, Oxford, pp 377–389
14. Wong P, Cuello C, Bertouch JV et al (2000) The effects of pulse methylprednisolone on matrix
metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis.
Rheumatology 39:1067–1073
15. Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14:353–357
16. Dunicz-Sokolowska A, Długaszek M, Radomska K, Wlaźlak E, Surkont G, Graczyk A (2007) Contents
of bioelements and toxic metals in the Polish population determined by hair analysis. Part III. Adults
aged 20–40 years. Magnes Res 20:43–52
17. Ho J, Boeheim F, Pangborn J, Spitz J, Smith B (2001) Hair element testing: clinical utility and reliability.
Great Smokies Diagnostic Laboratory, Asheville
18. Seidel S, Kreutzer R, Smith D, McNeel S, Gillis D (2001) Assessment of commercial laboratories
performing hair mineral analysis. JAMA 285:67–72
19. Wang CT, Li YJ, Wang FJ, Shi YM, Lee BT (2008) Correlation between the iron, magnesium, potassium
and zinc content in adolescent girls’ hair and their academic records. Chang Gung Med J 31:358–363
20. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised
criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
21. Ritchie DM, Boyle JA, McInnes JM et al (1968) Clinical studies with an articular index for the
assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 147:393–406
22. Wells G, Becker JC, Teng J et al (2009) Validation of the 28-joint Disease Activity Score erythrocyte
sedimentation rate comparison with the DAS28 based on in patients withrheumatoid arthritis, and C-
Zinc Levels in Patients with Rheumatoid Arthritis 861reactive protein against disease progression response criteria based on (DAS28) and European League
Against Rheumatism. Ann Rheum Dis 68:954–960
23. Radomska K, Graczyk A, Konarski J (1993) Contents of macro- and microelements in human body
determined by hair analysis. Populational studies. Clin Chem Enzym Comms 5:105–118
24. Balogh Z,El-GhobareyAF, FellGS,Brown DH,DunlopJ, DickWC(1980) Plasma zinc and its relationship
to clinical symptoms and drug treatment in rheumatoid arthritis. Ann Rheum Dis 39:329–332
25. Çaglayan O, Sükrü Aydog Y (1997) Serum zinc and copper levels in rheumatoid arthritis. J Islamic Acad
Sci 10:19–24
26. Dore-Duffy P, Peterson M, Catalanotto F et al (1990) Zinc profiles in rheumatoid arthritis. Clin Exp
Rheumatol 8:541–546
27. Milanino R, Frigo A, Bambara LM et al (1993) Copper and zinc status in rheumatoid arthritis: studies of
plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological
treatment. Clin Exp Rheumatol 11:271–281
28. Yazar M, Sarban S, Kocyigit A, Isikan UE (2005) Synovial fluid and plasma selenium, copper, zinc, and
iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res
106:123–132
29. Szpak A, Szechciński J, Kowalski M (1996) Trace elements in blood serum and joint fluid in rheumatoid
arthritis [Pierwiastki śladowe w surowicy krwi i płynie stawowym w reumatoidalnym zapaleniu
stawów]. Reumatologia 34:229–233
30. Konarski J, Radomska K, Graczyk A (1993) Zinc its role and functions in metabolic processes of
human’s organism [Cynk jego rola i funkcje w procesach metabolicznych organizmu człowieka]. Mag
Med 4:13–19
862 Mierzecki et al.